About
Looking for more information?
Contact our responsive and friendly client services team any time.
INVESTOR PRESENTATION - CYNATA THERAPEUTICS LIMITED
CYNATA THERAPEUTICS LIMITED
Health Care
Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company developing therapies based on its proprietary CymerusA stem cell technology platform. The company intends to commercialise the use of MSC therapies worldwide to address a wide range of medical issues.
Read moreMarket Cap
93.70m
Price at Close
$0.8
4w avg. Volume
205.26k
4w avg. Turnover
$184.19k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| -4.19% | 23 Oct 2020 |
| -4.19% | 23 Oct 2020 |
| -2.53% | 06 Oct 2020 |
| -1.92% | 23 Sep 2020 |
| +19.88% | 14 Sep 2020 |
| +19.88% | 14 Sep 2020 |
| +4.07% | 06 Sep 2020 |
| -5.91% | 25 Aug 2020 |
| -5.91% | 25 Aug 2020 |
| -7.98% | 23 Aug 2020 |
Market Data
Current Price
$0.8
52WK HIGH
$1.35
52WK LOW
$0.58
1YR RETURN
-39.39%
1YR RETURN VS. SECTOR
-58.49%
90 DAY RETURN
+28.00%
ASX RANK
807
/2,015
SECTOR RANK
16
/47
SHARES OUTSTANDING
117.12m
CYNATA THERAPEUTICS LIMITED
Health Care
Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company developing therapies based on its proprietary CymerusA stem cell technology platform. The company intends to commercialise the use of MSC therapies worldwide to address a wide range of medical issues.
Read moreMarket Cap
93.70m
Price at Close
$0.8
4w avg. Volume
205.26k
4w avg. Turnover
$184.19k
ASX:CYP is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia